Peter Fedichev

CEO, Co-Founder

Physicist-turned-biotech innovator, Peter Fedichev is the CEO of Gero, a company he founded in 2015 to combat aging and complex diseases. A top-cited physicist with a PhD from the University of Amsterdam and over 75 publications, he uses his deep expertise in physics and data science to drive innovation at the intersection of AI and human health, leveraging over 20 years of experience.

Maxim Kholin

Co-founder, Head of Corporate Affairs

Biotech entrepreneur with 20+ years of experience, Maxim co-founded Gero to develop therapies against aging. He leads corporate affairs, legal strategy, fundraising, and investor relations, holding master's degrees in law and economics. His mission is to end age-related diseases through science-enabled progress, having initiated and closed numerous licensing and investment deals.

Alex Kadet

CBO

As Chief Business Officer at Gero Alex leads global business strategy and partnerships to accelerate AI-driven therapeutics against age-related diseases. With over 7 years of experience in biotech business development, he drives collaborations with biotech, academia, and pharmaceutical companies to transform Gero's cutting-edge science into real-world therapeutics.

Alexandr Sviridov

COO

Experienced tech entrepreneur and operational leader with multiple exits, including to Samsung. Aleksandr brings over a decade of expertise managing multidisciplinary teams and driving ambitious projects from concept to successful outcomes. As a longevity maximalist, he is deeply committed to Gero’s mission of stopping aging and chronic diseases through cutting-edge biotech and AI innovation.

Yuri Melnichek

Board Member

Serial tech entrepreneur and investor with a proven track record of successful exits, including acquisitions by Google, Pinterest, and Farfetch. Yuri brings deep expertise in Machine Learning, Computer Vision, and AI, coupled with a proven ability to lead companies toward sustained growth and strategic exits.

Brian Kennedy, PhD

Independent Director

Globally renowned longevity researcher, Distinguished Professor of Biochemistry & Physiology at the National University of Singapore, and Director of the Centre for Healthy Longevity at the National University Health System (NUHS). Brian previously served as President and CEO of the Buck Institute for Research on Aging, the premier independent aging research center in the U.S. He also holds adjunct professorship at USC’s Leonard Davis School of Gerontology, among other academic roles. Brian brings deep expertise in translating cutting-edge science into transformative therapies against aging and age-related diseases.